People who live in wealthier, more advantaged neighborhoods have a slightly higher chance of being diagnosed with pancreatic cancer than those in lower-income areas. A large-scale study of over 31,000 U.S. veterans – published in 2026 in JNCI Cancer Spectrum – cuts against one of the most consistent patterns in cancer research, where disadvantage almost universally drives worse outcomes. The explanation the research team suspects comes down to who gets to see a doctor in the first place.
A Yale-led study published in JNCI Cancer Spectrum is the first to examine the overall relationship between pancreatic cancer and neighborhood-level socioeconomic factors. The question the researchers set out to answer was straightforward: does the neighborhood where you live influence your chance of developing the most lethal major cancer in the United States? The answer they found was not the one they expected.
“For some common cancers, a person’s neighborhood is correlated with their likelihood of developing the disease,” says Louise Wang, MD, assistant professor of medicine (digestive diseases) at Yale School of Medicine and senior author of the study. “We wanted to understand if this holds true for pancreatic cancer. Are individual-level risk factors, like genetics and lifestyle, the most significant, or do neighborhood-level factors play a role in the development of this cancer?”
The Scale and Severity of Neighborhoods and Pancreatic Cancer
Pancreatic cancer is an aggressive disease that often remains silent, leading to diagnoses at later stages when it is more difficult to treat. That silence is the central clinical problem: by the time symptoms appear, the window for effective intervention is frequently already closed.
According to data from the National Cancer Institute’s SEER program, in 2026 it is estimated that there will be 67,530 new cases of pancreatic cancer and an estimated 52,740 people will die of this disease. Pancreatic cancer has the highest mortality rate of all major cancers and is currently the third leading cause of cancer-related death in the United States. Its overall five-year survival rate of 13.7% – meaning fewer than 1 in 7 patients survives five years – reflects how rarely the disease is caught while still treatable.
The five-year relative survival rate for localized pancreatic cancer is 44%, yet fewer than 20% of patients have tumors confined to the pancreas at the time of diagnosis. About 80% of patients are diagnosed after the disease has reached an advanced stage – a figure that has barely shifted in decades, and one that explains why early detection remains the field’s most urgent unsolved problem. The disease is more common with increasing age and slightly more common in men than women.
Pancreatic ductal adenocarcinoma (PDAC) remains the most common and deadly form, and individual-level social determinants of health have already been associated with PDAC diagnosis. What had never been studied before was whether the neighborhood itself – independent of individual factors like smoking history, diabetes, or family genetics – plays a role in whether someone gets diagnosed at all.
The Yale Study: Design and Key Finding
The researchers – Rachel N. Levinson, Ryan Bushman, Catherine Mezzacappa, Janet P. Tate, Amy C. Justice, and Louise L. Wang – conducted a retrospective cohort study of 5,069,429 patients in the Veterans Health Administration between October 1, 2001, and December 31, 2021. From that massive dataset, they identified 31,242 veterans diagnosed with the most common form of pancreatic cancer who also had Area Deprivation Index data available.
The Area Deprivation Index, or ADI, is the tool the team used to classify each patient’s neighborhood. The ADI ranks neighborhoods on the basis of socioeconomic disadvantage, incorporating factors such as income, education, employment, and housing quality. It draws on 17 U.S. Census variables and produces a score that allows researchers to compare neighborhoods across the country on a standardized scale, rather than relying on crude proxies like zip code income alone.
The study published in JNCI Cancer Spectrum found that veterans living in neighborhoods with the highest level of advantage had a slightly increased risk of being diagnosed with pancreatic cancer – and this was true even when accounting for clinical and lifestyle risk factors for pancreatic cancer. The finding held up after researchers controlled for known individual-level contributors to the disease, including diabetes, obesity, smoking, and chronic infections. The neighborhood effect was small but statistically consistent.
Wang noted that the team “was not expecting to see that individuals living in neighborhoods with higher incomes, education levels, and other forms of advantage would have increased risk of pancreatic cancer.” Previous studies examining neighborhood disadvantage and cancer incidence had found the opposite pattern for most other tumor types: disadvantaged neighborhoods typically correlate with higher cancer rates, not lower ones.
Why Advantaged Neighborhoods May Show More Diagnoses
The study found a small statistical link between advantaged neighborhoods and pancreatic cancer diagnosis that remained after accounting for many known risk factors – but the team does not conclude that affluence causes the disease. One possible explanation is that people in wealthier neighborhoods may have better access to medical care, imaging tests, and specialist services, meaning pancreatic cancer could be detected more often rather than actually occurring more frequently. This is a detection bias hypothesis, and it’s not without precedent. Research on pancreatic neuroendocrine tumors, a related pancreatic malignancy, has shown that rising incidence among higher-income populations is “probably explained by improved detection, particularly among populations with greater access to healthcare, rather than by a true increase in disease occurrence.”
The practical implication is significant. If people in lower-income neighborhoods are developing pancreatic cancer at similar or higher rates, but those cancers are simply going undetected, the real-world consequences fall disproportionately on those communities. The disease would be progressing to advanced stages – and killing people – before it ever reaches the medical record. That wouldn’t register as a higher diagnosis rate in any study, but it would still represent a massive and invisible health burden.
Access to imaging is where these disparities become concrete. A 2025 study published in BMC Health Services Research found that access to cancer care remains highly unequal, particularly in remote and rural areas, and that lower household income is associated with poor imaging quality due to technologist-related issues like improper positioning. The same research found that Black and Hispanic women are 17% more likely than White patients to have missed or undetected lesions on imaging. For a cancer that is already notoriously difficult to detect, that gap in imaging quality translates directly into missed diagnoses and later-stage presentations.
The Veteran Population and What It Tells Us
One reason the Yale team chose the Veterans Health Administration (VHA) as a study population is that it partially controls for one of the most confounding variables in health equity research: insurance status. A prior study using a similar tool to the ADI investigated PDAC outcomes of resection and survival within the VA population and similarly observed no differences among levels of neighborhood social deprivation, suggesting that the VA’s relatively equal access system may overcome neighborhood-level inequalities. When access to care is equalized – as it largely is within the VA – the survival disadvantage associated with poorer neighborhoods may diminish.
That finding is both encouraging and instructive. The VA system’s relatively uniform access structure appears to neutralize some of the socioeconomic gradient that predicts worse outcomes in the general population. Although there have been recent treatment advances, researchers still have many questions about why pancreatic cancer develops and how to screen for it.
Outside the VA system, the picture is considerably grimmer. Neighborhood-level socioeconomic disadvantage, as captured by the ADI, is a strong independent predictor of reduced access to specialized pancreatic cancer care, according to a 2025 study published in PLOS ONE by researchers at the University of Wisconsin-Milwaukee. Factors such as education level, income, and insurance status are significantly associated with increased utilization of these vital services.
Survival Gaps Even After Surgery
The neighborhood effect doesn’t end at diagnosis. A separate 2026 study published in the Journal of the American College of Surgeons by researchers at the University of Alabama at Birmingham examined whether receiving guideline-concordant treatment could overcome socioeconomic disadvantage. It could not. Residence in a socioeconomically disadvantaged area independently predicts decreased survival, even after adjusting for clinical factors and guideline-concordant treatment. The authors suggest that strategies such as transportation assistance and nutritional support may be needed to help close the gap.
Social determinants of health – namely economic stability, education, race, and insurance status – play an important role in cancer-related outcomes, according to a June 2025 review published in Cancers that analyzed the full body of U.S.-based research on social determinants and pancreatic cancer care. The review also noted that only one in every five patients has resectable disease at the time of presentation, a figure that underscores how central early detection is to any conversation about outcomes equity.
For patients in high-ADI neighborhoods who do make it to surgery, the road after the operating room is steeper. A study examining pancreatic cancer patients who underwent the Whipple procedure – the major surgical resection used for operable disease – found that high-deprivation patients living far from care centers were significantly less likely to complete adjuvant chemotherapy after surgery, at a rate of 50% versus 73.2% for lower-deprivation patients. Adjuvant chemotherapy after resection is a key determinant of long-term survival.
Other Risk Factors Under Investigation
The Yale researchers are continuing to use Veterans Health Administration data to study other possible causes of pancreatic cancer, including hepatitis C infection, pollution exposure, and environmental exposures related to military service. One of those emerging risk factors has already yielded surprising results.
Earlier Yale research, published in November 2025 in JAMA Network Open, found that individuals with chronic hepatitis C virus infection have a 1.8-fold increased risk of pancreatic cancer compared to those without the virus. That makes chronic hepatitis C a stronger risk multiplier than diabetes, which increases pancreatic cancer risk by a factor of 1.2, or active smoking, which increases risk by a factor of 1.3. Hepatitis C is both treatable and more prevalent in lower-income communities, which adds another layer of complexity to the neighborhood-cancer relationship.
The VHA dataset is particularly well-suited for this kind of follow-on research. Early detection of PDAC improves survival, but screening recommendations are currently limited to individuals with hereditary risk, accounting for only 10% of PDAC. The remaining 90% of diagnoses occur in people with no family history, which is why researchers are working to develop better risk stratification tools from clinical records alone. A separate 2026 study from the same Yale group, published in Clinical and Translational Gastroenterology, demonstrated the feasibility of using electronic health record data across 9.4 million veterans to identify high-risk individuals for targeted screening before symptoms develop.
Read More: Living Near Golf Courses May Raise Parkinson’s Risk, Study Finds
What This Means for You
The primary finding from the Yale neighborhood study does not mean that living in a wealthy zip code puts you at greater risk of pancreatic cancer. The more likely explanation is that the disease is being found more reliably in people who can access imaging and specialist care, and going undetected – and untreated – in communities where that access is restricted. The problem, in other words, is structural rather than biological: equalize the access, and much of the disparity shrinks, as the VA data suggests.
For the individual, the most actionable conclusion is that the diagnosis stage is the single factor most tightly linked to survival. The five-year survival rate for localized disease is 44%, compared to a much lower rate for advanced disease, and that gap is directly tied to whether the disease is caught early. Anyone with known risk factors – including new-onset diabetes after age 50, unexplained weight loss, a family history of pancreatic cancer, or a diagnosis of chronic pancreatitis – should discuss the possibility of surveillance imaging with a physician. Waiting for symptoms is not a clinically safe strategy for this disease.
At the system level, the research reinforces a well-documented but still under-addressed reality: lower neighborhood socioeconomic status is associated with suboptimal cancer care and reduced survival across multiple cancer types, and pancreatic cancer is no exception. Equalizing access to imaging technology, specialist referrals, and post-surgical support are the structural interventions that the evidence consistently points toward. The VA system’s relatively equal-access model, which appears to reduce survival disparities by neighborhood, offers a template for what equitable care infrastructure can achieve when it is systematically built rather than left to individual circumstances.
Disclaimer: This information is not intended to be a substitute for professional medical advice, diagnosis, or treatment and is for information only. Always seek the advice of your physician or another qualified health provider with any questions about your medical condition and/or current medication. Do not disregard professional medical advice or delay seeking advice or treatment because of something you have read here.
AI Disclaimer: This article was created with the assistance of AI tools and reviewed by a human editor.
Read More: New Compounds Make Pancreatic Cancer Cells Destroy Themselves — Here’s the Science